Kane Biotech Management
Management criteria checks 3/4
Kane Biotech's CEO is Marc Edwards, appointed in Sep 2018, has a tenure of 6.17 years. total yearly compensation is CA$406.83K, comprised of 61.5% salary and 38.5% bonuses, including company stock and options. directly owns 4.64% of the company’s shares, worth $502.34K. The average tenure of the management team and the board of directors is 2.6 years and 6.2 years respectively.
Key information
Marc Edwards
Chief executive officer
CA$406.8k
Total compensation
| CEO salary percentage | 61.5% |
| CEO tenure | 6.2yrs |
| CEO ownership | 4.6% |
| Management average tenure | 2.6yrs |
| Board average tenure | 6.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CA$5m |
| Mar 31 2024 | n/a | n/a | -CA$5m |
| Dec 31 2023 | CA$407k | CA$250k | -CA$5m |
| Sep 30 2023 | n/a | n/a | -CA$4m |
| Jun 30 2023 | n/a | n/a | -CA$4m |
| Mar 31 2023 | n/a | n/a | -CA$4m |
| Dec 31 2022 | CA$303k | CA$242k | -CA$4m |
| Sep 30 2022 | n/a | n/a | -CA$4m |
| Jun 30 2022 | n/a | n/a | -CA$5m |
| Mar 31 2022 | n/a | n/a | -CA$5m |
| Dec 31 2021 | CA$329k | CA$225k | -CA$5m |
| Sep 30 2021 | n/a | n/a | -CA$4m |
| Jun 30 2021 | n/a | n/a | -CA$4m |
| Mar 31 2021 | n/a | n/a | -CA$3m |
| Dec 31 2020 | CA$353k | CA$225k | -CA$4m |
| Sep 30 2020 | n/a | n/a | -CA$4m |
| Jun 30 2020 | n/a | n/a | -CA$4m |
| Mar 31 2020 | n/a | n/a | -CA$2m |
| Dec 31 2019 | CA$311k | CA$225k | -CA$960k |
| Sep 30 2019 | n/a | n/a | -CA$510k |
| Jun 30 2019 | n/a | n/a | -CA$685k |
| Mar 31 2019 | n/a | n/a | -CA$3m |
| Dec 31 2018 | CA$85k | CA$67k | -CA$3m |
| Sep 30 2018 | n/a | n/a | -CA$4m |
| Jun 30 2018 | n/a | n/a | -CA$4m |
| Mar 31 2018 | n/a | n/a | -CA$4m |
| Dec 31 2017 | CA$18k | n/a | -CA$3m |
Compensation vs Market: Marc's total compensation ($USD291.06K) is below average for companies of similar size in the US market ($USD652.28K).
Compensation vs Earnings: Marc's compensation has increased whilst the company is unprofitable.
CEO
Marc Edwards
6.2yrs
Tenure
CA$406,832
Compensation
Mr. Marc Edwards is the Founder and President of VetRx, a Montreal-based technology company specializing in daollection, cleansing, marketing and pharmaceutical compliance for the veterinary industry. Mr....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.2yrs | CA$406.83k | 4.64% $ 502.3k | |
| Chief Financial Officer | 7.2yrs | CA$231.39k | 0.72% $ 77.5k | |
| Executive Chairman & Member of Scientific Advisory Board | 6.2yrs | no data | 0.24% $ 26.1k | |
| Chief Scientific Officer & Member of Scientific Advisory Board | 2.6yrs | no data | no data | |
| Investor Relations | no data | no data | no data | |
| Director of Marketing | no data | no data | no data | |
| Chief Quality Officer | less than a year | no data | no data | |
| Investor Relations Adviser | no data | no data | no data |
2.6yrs
Average Tenure
Experienced Management: KNBI.F's management team is considered experienced (2.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 8.8yrs | CA$406.83k | 4.64% $ 502.3k | |
| Executive Chairman & Member of Scientific Advisory Board | 6.2yrs | no data | 0.24% $ 26.1k | |
| Chief Scientific Officer & Member of Scientific Advisory Board | 2.8yrs | no data | no data | |
| Independent Director | 4.5yrs | CA$41.53k | 0.11% $ 11.8k | |
| Vice Chairman | 14.2yrs | CA$44.73k | 18.46% $ 2.0m | |
| Member of Scientific Advisory Board | 6.2yrs | CA$13.30k | no data | |
| Chairman of Scientific Advisory Board | 6.2yrs | no data | no data | |
| Independent Director | less than a year | CA$2.25k | no data |
6.2yrs
Average Tenure
Experienced Board: KNBI.F's board of directors are considered experienced (6.2 years average tenure).